VV169, an experimental cellular therapy being developed by Vyriad to treat myeloma, is expected to enter clinical testing in 2026, the…
Myeloma
This morning, while I was making myself a cup of coffee, I saw my reflection in the curved, stainless steel surface of the kettle as…
Johnson & Johnson (J&J) is asking the U.S. Food and Drug Administration (FDA) to approve a combination of two medications, Tecvayli (teclistamab) and…
A caregiver’s energy is a rare currency. When we spend it, we’re not doing so in single, large transactions. Instead, we’re making thousands of tiny…
Most people with hard-to-treat myeloma were still alive and free from disease progression two years after treatment with anito-cel (anitocabtagene autoleucel), an experimental cell…
As I write this, yesterday was Tuesday. Perhaps it was a great day for someone who got a promotion or received a gift. But for…
Most myeloma patients who started treatment at the Berenson Cancer Center — a clinic in California that specializes in myeloma care — lived…
Ever since my mum was diagnosed with myeloma, I’ve had to rewrite my vocabulary. My days are no longer filled with deadlines and projects,…
Thermo Fisher Scientific has received U.S. Food and Drug Administration (FDA) clearance for its EXENT System, an automated test that helps doctors diagnose multiple…
When you or someone you know is suspected of having a rare cancer like myeloma, it is natural to prepare for the worst. You…
Recent Posts
- Vyriad targets 2026 clinical trial for new experimental cell therapy VV169
- Olverembatinib and chemo show deep response in trial for Ph-positive ALL
- Pancreatic cancer treatment atebimetinib set for Phase 3 trial
- 1st trial participant receives Alpha DaRT radiation therapy for glioblastoma
- How my reflection has changed since becoming a caregiver
